Follow-up of biologic monitoring results in cadmium workers removed from exposure

Melissa A. McDiarmid, Caroline S. Freeman, Elizabeth A. Grossman, John Martonik

Research output: Contribution to journalArticle

Abstract

Biological monitoring and exposure monitoring data for employees at a nickel-cadmium battery production facility were made available to OSHA for review. Sixteen employees were medically removed from occupational exposures to cadmium due to elevated levels of biological parameters (CdB, Cdu, B2U). While the biological monitoring parameters for most workers significantly declined during the 18 months of medical removal, the biological parameters for only one employee's values returned to the normal range. Only one worker had frank renal dysfunction, based on beta-2-microglobulin levels at the time of removal; this dysfunction remained throughout the 17 months of observation after medical removal. Significant policy implications of medical removal protection beyond the current 18-month period provided by the cadmium standards exist and require physician discretion. Mitigating issues which may make it ethically appropriate to return an employee to work despite elevated biologic monitoring parameters are also discussed.

Original languageEnglish (US)
Pages (from-to)261-267
Number of pages7
JournalAmerican Journal of Industrial Medicine
Volume32
Issue number3
DOIs
StatePublished - Sep 1997
Externally publishedYes

Fingerprint

Environmental Monitoring
Cadmium
United States Occupational Safety and Health Administration
beta 2-Microglobulin
Return to Work
Occupational Exposure
Nickel
Reference Values
Observation
Physicians
Kidney

Keywords

  • Biological monitoring
  • Cadmium
  • Medical removal protection
  • OSHA

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Follow-up of biologic monitoring results in cadmium workers removed from exposure. / McDiarmid, Melissa A.; Freeman, Caroline S.; Grossman, Elizabeth A.; Martonik, John.

In: American Journal of Industrial Medicine, Vol. 32, No. 3, 09.1997, p. 261-267.

Research output: Contribution to journalArticle

McDiarmid, Melissa A. ; Freeman, Caroline S. ; Grossman, Elizabeth A. ; Martonik, John. / Follow-up of biologic monitoring results in cadmium workers removed from exposure. In: American Journal of Industrial Medicine. 1997 ; Vol. 32, No. 3. pp. 261-267.
@article{7a8cf390f4b44b20a643d2be1792a1cc,
title = "Follow-up of biologic monitoring results in cadmium workers removed from exposure",
abstract = "Biological monitoring and exposure monitoring data for employees at a nickel-cadmium battery production facility were made available to OSHA for review. Sixteen employees were medically removed from occupational exposures to cadmium due to elevated levels of biological parameters (CdB, Cdu, B2U). While the biological monitoring parameters for most workers significantly declined during the 18 months of medical removal, the biological parameters for only one employee's values returned to the normal range. Only one worker had frank renal dysfunction, based on beta-2-microglobulin levels at the time of removal; this dysfunction remained throughout the 17 months of observation after medical removal. Significant policy implications of medical removal protection beyond the current 18-month period provided by the cadmium standards exist and require physician discretion. Mitigating issues which may make it ethically appropriate to return an employee to work despite elevated biologic monitoring parameters are also discussed.",
keywords = "Biological monitoring, Cadmium, Medical removal protection, OSHA",
author = "McDiarmid, {Melissa A.} and Freeman, {Caroline S.} and Grossman, {Elizabeth A.} and John Martonik",
year = "1997",
month = "9",
doi = "10.1002/(SICI)1097-0274(199709)32:3<261::AID-AJIM12>3.0.CO;2-T",
language = "English (US)",
volume = "32",
pages = "261--267",
journal = "American Journal of Industrial Medicine",
issn = "0271-3586",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Follow-up of biologic monitoring results in cadmium workers removed from exposure

AU - McDiarmid, Melissa A.

AU - Freeman, Caroline S.

AU - Grossman, Elizabeth A.

AU - Martonik, John

PY - 1997/9

Y1 - 1997/9

N2 - Biological monitoring and exposure monitoring data for employees at a nickel-cadmium battery production facility were made available to OSHA for review. Sixteen employees were medically removed from occupational exposures to cadmium due to elevated levels of biological parameters (CdB, Cdu, B2U). While the biological monitoring parameters for most workers significantly declined during the 18 months of medical removal, the biological parameters for only one employee's values returned to the normal range. Only one worker had frank renal dysfunction, based on beta-2-microglobulin levels at the time of removal; this dysfunction remained throughout the 17 months of observation after medical removal. Significant policy implications of medical removal protection beyond the current 18-month period provided by the cadmium standards exist and require physician discretion. Mitigating issues which may make it ethically appropriate to return an employee to work despite elevated biologic monitoring parameters are also discussed.

AB - Biological monitoring and exposure monitoring data for employees at a nickel-cadmium battery production facility were made available to OSHA for review. Sixteen employees were medically removed from occupational exposures to cadmium due to elevated levels of biological parameters (CdB, Cdu, B2U). While the biological monitoring parameters for most workers significantly declined during the 18 months of medical removal, the biological parameters for only one employee's values returned to the normal range. Only one worker had frank renal dysfunction, based on beta-2-microglobulin levels at the time of removal; this dysfunction remained throughout the 17 months of observation after medical removal. Significant policy implications of medical removal protection beyond the current 18-month period provided by the cadmium standards exist and require physician discretion. Mitigating issues which may make it ethically appropriate to return an employee to work despite elevated biologic monitoring parameters are also discussed.

KW - Biological monitoring

KW - Cadmium

KW - Medical removal protection

KW - OSHA

UR - http://www.scopus.com/inward/record.url?scp=0030802959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030802959&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0274(199709)32:3<261::AID-AJIM12>3.0.CO;2-T

DO - 10.1002/(SICI)1097-0274(199709)32:3<261::AID-AJIM12>3.0.CO;2-T

M3 - Article

C2 - 9219656

AN - SCOPUS:0030802959

VL - 32

SP - 261

EP - 267

JO - American Journal of Industrial Medicine

JF - American Journal of Industrial Medicine

SN - 0271-3586

IS - 3

ER -